跳至主要内容
临床试验/NL-OMON27421
NL-OMON27421尚未招募不适用

A prospective, explorative cohort study to identify biomarkers of treatment response in oropharyngeal cancer.

Erasmus MC0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
Erasmus MC
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • To be eligible participating in this study, patients must meet all the following criteria:
  • Clinical diagnosis of squamous cell carcinoma of the oropharynx, with or without histological confirmation
  • In case of already histology-confirmed oropharyngeal cancer - primary tumor accessible for re-sampling without general anaesthesia
  • Eligible for curative treatment with radiotherapy with or without the addition of systemic agents
  • Written informed consent obtained
  • Age >= 18 years

排除标准

  • The following patients are not eligible for participation in this study:
  • Patients with histology-confirmed oropharyngeal cancer, safely accessible for re-sampling only under general anaesthesia
  • Patients currently under treatment for other malignant disease (unless basal cell carcinoma of the skin)
  • Previous radiotherapy in the head and neck area (with overlapping RT area)
  • Recurrent oropharyngeal cancer

研究者

发起方
Erasmus MC

相似试验